Fennec Announces Results of Annual Meeting
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Fennec Pharmaceuticals announced the results of its Annual General Meeting of Shareholders held on June 25, 2024, in New York. The nominees listed in the April 29, 2024, management proxy circular were elected as directors, with high approval ratings. Notably, Dr. Khalid Islam received 96.45% of votes in favor, while Mr. Chris A. Rallis received 92.52%. Shareholders also voted 97.96% in favor of appointing Haskell & White LLP as auditors and 93.87% in favor of the executive compensation plan.
Positive
- High approval ratings for board nominees, with Dr. Khalid Islam receiving 96.45% of votes.
- 97.96% shareholder approval for appointing Haskell & White LLP as auditors.
- 93.87% shareholder approval for the executive compensation plan.
Negative
- None.
Details
News Market Reaction – FENC
The recorded move for FENC in the trading session of this news was -2.90%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
RESEARCH TRIANGLE PARK, N.C., June 25, 2024 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (the “Company”) (NASDAQ:FENC) (TSX:FRX) today announced that the nominees listed in the management proxy circular dated April 29, 2024 (the “Circular”) for the Annual General Meeting of Shareholders were elected as directors of the Company at the Annual General Meeting of Shareholders held in New York, New York on June 25, 2024.
Detailed results of the vote for the election of directors are set out below:
| Name of Nominee | Votes For | % Votes For | Votes Withheld | % Votes Withheld |
| Dr. Khalid Islam | 10,100,238 | 371,270 | ||
| Mr. Chris A. Rallis | 9,688,517 | 782,991 | ||
| Mr. Marco Brughera | 9,801,305 | 670,203 | ||
| Dr. Jodi Cook | 8,991,182 | 1,480,326 | ||
| Mr. Rostislav Raykov | 9,859,679 | 611,829 |
Shareholders voted
For further information, please contact:
Rosty Raykov
Chief Executive Officer
Fennec Pharmaceuticals Inc.
T: (919) 636-5144
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.